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ICU → Intensive care unit
CBD → Common Bile Duct
APACHE → Acute Physiological And Chronic Health Evaluation
CT → Computer Tomography
ARDS →  Acute Respiratory Distress Syndrome
DIC → Disseminated Intravascular Coagulation
SAPS → Simplified Acute Physiological Score
MRCS → Medical research council sepsis score
CVP → Central Venous Vressure
MAP → Mean Arterial Pressure
NPO → Nil Per Oral
MRI → Magnetic Resonance Imaging
PCD → Per Cutaneous Drainage
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USG → Ultrasonography
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ABSTRACT
BACKGROUND AND OBJECTIVES
Acute pancreatitis accounts for 3% of all cases of acute abdomen
it occurs in any age group but peak incidence is in young men and older
women.
There are two major causes of acute pancreatitis-alcohol and
biliary disease which accounts 50-70% of total cases. The pathological
spectrum varies from edematous pancreatitis which is uncomplicated
and self limiting to necrotizing pancreatitis in which degree of pancreatic
necrosis correlate the severity of attack and systemic complication which
involve renal, lung, git, brain and may lead to multi system organ
failure.
METHODS
It is hospital based prospective study. The study was conducted
in hospitals attached Madras medical college during the study period
from March 2014 to August 2014. 100 consecutive complicated cases
were analyzed.
RESULTS
Out of 100 patients 93 were male and 7 female. The peak
incidence in male is 5th decade and in female 2rd decade in life.
Alcohol accounts72% of total cases and 16% biliary disease.26 patients
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found to have systemic complication and 58 local complications, most
systemic complications were managed in general ward except few in
ICU those associated with ARDS and septicemia. 34% of patient had 
recurrent attack supportive care in ICU for the period of 3 weeks, 80%
resolved, infected necrosis were managed by necrosectomy, mortality
33%. Pancreatic abscess were managed by USG/CT guided aspiration.
CONCLUSIONS
Acute pancreatitis is one of the common differential diagnosis of
acute abdomen specially alcoholics and biliary disease. Patients with
acute pancreatitis should be evaluated clinically, biochemically and
radiologically as this condition associated with severe systemic and local
complications
KEY WORDS
Acute pancreatitis, pseudocyst, necrosis, abscess.
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1INTRODUCTION
Acute pancreatitis has been recognized since antiquity1,2 but
the importance of pancreas and the severity of its inflammatory 
disorders were realized only in middle of 19th century3.
The nature of disease was recognized way back in 1925 when
Moynihan described acute pancreatitis as “ The most terrible of all
the calamities that occur in connection with abdominal viscera4 “ but
even today with technical advantage  in  medical  and  surgical  field  
acute pancreatitis remains a major cause of morbidity and 
mortality5,6.
Acute pancreatitis is a common disorder. The data available are
mainly from united states and united kingdom. It has been noticed in 
most of the studies that there is in an increase in the incidence of 
disease by a factor of 10 in the past 3 decades. The reason for the 
increase is speculated to be due to increase in alcohol abuse and an
improved ability to diagnose the disease. But the disease has been a
cause of significant morbidity and mortality. Both sexes are equally
affected.
Acute pancreatitis is related to alcohol or biliary tract stone 
disease in 80% of Cases. The remaining 10% is related to metabolic
2factor, drugs and other condition  and  10%  are idiopathic3,6. 
However the variation in the frequency of different forms of
pancreatitis from source to source is quite varied and depends on
country of origin and the population studied.
Acute pancreatitis has been classified way back in 1882 in to 
apoplectic and sub acute forms. Later in 1963 in a symposium at 
Marseilles a classifications based on the morphology was accepted 
until 1993 when it was realized that the earlier classification was 
possible only after surgery or during autopsy, so a classification
system was very much needed at the outset of the disease for a 
working diagnosis. Finally a classification system, which is
clinically based, was established in the Atlanta  symposium 1n  19937.
Acute pancreatits is a pathological broad spectrum of disease
ranging from parenchymal edema to severe necrotizing pancreatitis.
Clinical presentations varies from mild abdominal discomfort to
hypotension, metabolic derangement, sepsis, fluid sequestration, multiple
organ failure and death. 9 of 10 experience mild to moderate course
and self-limited, and 1 of 10 experience a severe life threatening form of
acute pancreatitis. Based on the above it is presently classified into
mild acute pancreatitis associated with minimal organ dysfunctions
and uneventful recovery, and severe acute pancreatitis associated with 
3organ failure and \or local complications such as necrosis,
abscess or pseudo cyst7.
Diagnosis remain clinical and can be supported by 1.5 – 2 fold
increase above the upper limit of normal of serum amylase8. But an 
estimation of serum lipase, trysinogen or isoamylase assay are 
confirmatory8 and will increase the diagnostic yield. Supportive
radiological procedure are sonography , computed tomography and
MRI . Currently CECT is the imaging modality of choice where  areas  
of  hypo perfusion  correlate  with  necrosis9.
The treatment of acute pancreatitis is largely supportive. Patient
with mild disease are treated by eliminating oral intakes, instituting
intravenous hydration and providing frequent parenteral analgesia. Use
of antibiotics and drugs, which reduce the pancreatic secretion, have
been studied extensively6. Except for imipenem and somatostanin,
which has shown benefit, no other drug have shown any promising
result. For practical purpose  no  specific  non-operative measure have
yet been shown to improve the outcome in acute in acute pancreatitis.
In the surgical management there are various diagnostic,
prophylactic and therapeutic option available for both the disease 
process and its complication but none of them have shown to
improve the outcome in acute  pancreatitis.
4An increased mortality rate associated with the disease is due to
inability to asses the severity of the disease at the outset . Various
prognostic scoring systems have been developed involving multiple
factor and single factor. The drawback with the current severity scoring
system is that they are cumbersome and time consuming and lack
sensitivity and specificity. In fact there necessity has been
questioned10.
Due to change in classification system, lack of statistics in our 
country and lack of accuracy of scoring system, a better sensitive,
specific, severity scoring system which can predict at the outset of the
disease is very much needed at present.
This study aims at various complications associated with 
acute attack of acute pancreatitis and their management.
5AIMS & OBJECTIVES OF THE STUDY
1. To evaluate the various causes acute pancreatitis through proper
clinical, biochemical and radiological examination.
2. To study clinical outcome of acute pancreatitis in each etiological 
factor
6REVIEW OF LITERATURE HISTORICAL
REVIEW OF ACUTE PANCREATITIS
The earliest description of pancreas dates back to 300BC,
given by Herophilus of Chalkaidon. During 100 AD Rufus of 
Ephesus thought that pancreas acts as a cushion for stomach and 
named it as “ pancreas” meaning “all flesh”.
But the earliest description of pancreatitis was available only in
1579 by the French surgeon, Ambrose pares. During the next two
centuries, a number of Anecdotal descriptions of pancreatic disease
were published. In 1642, Johann Wirsung describe main pancreatic
duct and in 1724 GD Santorini describe accessory  pancreatic duct
which  go by  their  names.
It was only in 1856 that Ancelet prepared a pathological
description of acute pancreatitis, pancreatic gangrene and abscess 
from a review of the reports existing at that time. This gave rise to
operative intervention on the pancreas,  which  was  first attempted  by 
Le  Dentu 1862.
Le Dentu
7With the recognition of pancreatitis, various clinical and
pathological classification started coming in. First of its kind was by
Prince in 1882 who divided acute pancreatitis in to two form an
apoplectic and a Sub acute form. This   was   followed   by   Reginald   
Huber Fitz   circa,   a Boston   physician and pathologist.   In   1889   he   
gave   clinical   description   of acute   pancreatitis and reported the
pathological finding that allowed him to distinguish
the hemorrhagic,  supportive, and gangrenous form of  disease.
Reginald Huber
Fitz 
Nicholas Senn, a Chicago surgeon, suggested operative
intervention of acute Pancreatitis associated with pancreatic gangrene
or abscess formation in 1886.
             Nicholas Senn
8With the classification and pathological description of
pancreatitis, the search for the causative  factor  began.
In 1901 Opie, at the Johns Hopkins Hospital in Baltimore, 
documented a gallstone impacted in the ampulla of vater during the  
postmortem examination of a patient, (operative on by Halsted) who
had died of gallstone pancreatitis and there by describe the pathogen
tic mechanism of gallstone pancreatitis. It was Synners in 1917 who
established alcohol as an important pathological  factor.
The importance of pancreas and the severity of its 
inflammatory disorders were only recognized in 1925 when Berkeley
George Andrew Moynihan (lord Moynihan of Leeds) professor of
clinical surgery, Leed, England, described acute pancreatitis as “The
most terrible of all the calamities that occur in connection with the
abdominal viscera”. This statement underscores the importance of acute
pancreatitis as a major cause of morbidity and mortality today.
In 1929 Elman.R, described  the  association  between elevated  
serum amylase level and acute pancreatitis. Watts in 1963 described total
pancreatectomy for acute pancreatitis.
In 1963 a symposium was held at Marseilles , where pancreatitis
was classified on the basis of pancreatitis morphology into Acute 
pancreatitis, Relapsing panrceatitis, Chronic pancreatitis, and Relapsing
9chronic pancreatitis. Lawson in 1970 described early laparotomy with
cholecystectomy, gastrostomy and pancreatic drainage in  severe  acute  
pancreatitis due to gallstone.
The prognostication of acute pancreatitis was done for the first 
time in 1974 by John HC Ranson when he was at New York
University Medical Centre, New York, Born in Bangalore , India
(1938) John Ranson rose to international prominence in medicine in
the field of pancreatic disease, and particularly acute pancreatitis. He
contributed profound knowledge about nonsurgical and surgical
management of acute pancreatitis and his contribution in this field
are fundamental to our present understanding of the disease and
its clinical management. He was the recipient of many honor and 
accepted as a leader in the field of acute pancreatitis.
Following Ranson prognostic stratification various stratification
systems started coming in. In 1978 from the department of surgery,
royal infirmary, Glasgow Clement W Imrie devised a grading system 
similar to Ranson where only 9 factor needed to be assessed; this
system is also well known as Glasgow scoring system. He further
modified this system to include only 8 factor also called modified
Glasgow  scoring  system.
Imrie is a very prominent person in the field of acute
pancreatitis. He has got various articles published in international 
10
journals to his credit, covering various aspect  of  acute  pancreatitis.
William A Knaus, from the department of anesthesiology,
George Washington university medical canter, in the year 1981
developed a system to quantify severity of illness in ICU patient called
APACHE system. This system attracted lot of criticism because of its 
inaccuracies. However it did serve as a prototype for the
development of two subsequent system APACHE I and APACHE II.
APACHE II has been widely applied for grading acute
pancreatitis. A recent addition is APACHE III system, which is yet to
be applied widely to acute pancreatitis.
In the year 1986, Agarwal N from department of surgery, our 
lady of mercy medical center, Bronx, New York, gave simplified
prognostic criteria for acute pancreatitis. He considered fluid 
requirement and early organ dysfunction as two main adverse
criteria for severity. One of these factor, fluid requirement is a factor
for evaluation in this study. The other factor, early organ dysfunction
has  now  been  included  in Atlanta a classification system.
In the field of imaging acute pancreatitis, Emil J Balthazar, 
Professor of Radiology, Bellevue Medical Center, New York, stands out
prominently. In 1989 he gave the CT grading of acute pancreatitis, and
emphasized the role of CT in the initial process of diagnosis, as an
early predictive indicator of disease severity,  and  in  detecting  
11
complication associated with acute pancreatitis.
Various ill defined terminologies and lot of confusion prevailed
with regards to acute pancreatitis. This lead to the symposium at 
Atlanta where in an universally accepted, clinically based classification
system for acute pancreatitis was developed in 1992, all the
terminologies related to acute pancreatitis were clearly defined and a
sound basis for future studies was established.
In 1993 Linda Rabeneck, physician from the development
of internal medicine, Yale university school of medicine, New 
Haven, constructed a new staging system with clinical and co-morbid 
features of patient with acute  pancreatitis.
Other prominent person who are actively involved and 
contributed a lot in the field of acute pancreatitis are Hans G Beger,
Ulm, Germany, Micheal J McMahan, department of surgery, general
infirmary Leeds, England, John P Neoptolemos, department of surgery, 
Birmingham, England; Edward L Bradley iii, department of surgery,
Atlanta, peter Banks, Boston, Buter A.
Indian clinicians who are actively involved in this field are
Shisish K Bhansali, Sharad C Shah, Jaslok hospital & Breach Candy 
hospital Mumbai, India, Sikora S S Department of Surgery, Sanjay
Gandhi institute of medical science Lucknow; Chaudhary A; department
of surgery; GB pant hospital New Delhi, India.
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Laparoscopic surgery is slowly superceding conventional
surgery; acute pancreatitis and its complication are amenable for 
laparoscopic intervention and are practiced successfully by increasing 
number of Indian surgeon, notable among  these  being  Udwadia,  
Chowbey, Palanivellu and Thanakumar.
EMBRYOLOGY OF PANCREAS
Embryogenesis of pancreas begins during the 4th week of
gestation. There are nine key processes involved in the development
of pancreas. Pancreas develop from two endoderm buds, dossal & 
ventral, that arise from that part of the gut that later form the second
part of the duodenum. The ventral bud arises in close relation to the
hepatic bud, in the inferior angle between it and duodenum. The dorsal
bud arises from the dorsal aspect of the gut.
Fig 1 : Development of PANCREAS - I
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Fig 2 : Development of PANCREAS - II
As the duodenum rotates to assume a C- shape configuration, the 
ventral bud comes to point to the right and dorsal bud to the left. As
a result of differential growth of the wall of gut, the attachment of the
ventral bud along with bile duct shift to left side.
Pancreatic tissue formed from these two buds now fuses to 
form one mass. The ventral bud form the lower part of the head,
and the uncinate process of the pancreas, while the upper part of 
the head, the body and tail are  formed  from the  dorsal  bud.
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Ventral duct and distal portion of dorsal duct form the main
pancreatic duct (duct of wirsung) and open in duodenum at the major
duodenal papilla , along with the bile duct , proximal dorsal duct form
accessory pancreatic duct (duct of santorini) and open in to duodenum
through a separate duodenal papilla
The secretary element of pancreas are formed by proliferation
of the primitive duct. The islets of Langerhans are also derived from
primitive duct system.
Malformation of pancreatic embryology
1-Heterotopic pancreas
Pancreatic tissue outside the confine of the main gland. Common
location are- stomach, duodenum, and small bowel or Meckel
diverticulum.
Rare  location- umbilicus, colon,  appendix, Gall bladder or Omentum.
Complication- intestinal obstruction, Ulceration, Hemorrhage.
Fig 3 : Endoscopic view of heterotropic pancreas in
stomach
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Fig 4 :-Pancrease  Divisum
Failure of two primordial ductal systems to fuse. Condition 
associated with pancreatitis.
3-Annular Pancreas
Failure of normal clockwise rotation of ventral pancreatic
primordial resulting in normal pancreatic tissue completely or
partially encircling the second portion of Duodenum.
Fig 5 :- Annular Pancreas
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SURGICAL ANATOMY OF PANRCEAS
The name “pancreas” is derived from the greek “Pan” (all) and
“Kreas” (flesh). It  was  originally  thought  to act as a cushion for the
stomach.
The gland is retroperitoneal lying posterior to the stomach and
lesser Omentum. It extends obliquely from the duodenal C- loop to a
more cephalad position in the hilum of the spleen. The gland weight 
from 75 to 125 gm, in length from 10 to 20cm, width from 3 to 5 
cm and thickness from 1.5 to 3.5 cm. The gland has a distinctive
yellow- tan- pink color and is multilobulated. The pancreas is covered
by peritoneum anteriorly and posteriorly it lies in proximity to the
inferior vena cava, the right renal vein, the aorta at the level of the
1st lumbar vertebra, the superior mesenteric vessel, and the splenic
vein. The gland is divided in to 4 portion :the Head, the neck, the 
body & the tail. The head lies with in the curve of the duodenum
overlying the body of the second lumbar vertebra and the vena cava.
The portion of pancreas anterior to superior mesenteric and portal vein 
is designated the neck of the gland. Coming of the side of the 
pancreatic head and passing to the left and behind the superior
mesenteric vein is the uncinate process of pancreas. The body of
pancreas lies immediately to left of the neck. The tail of pancreas 
17
extends to the left of the body into  the  splenic  hilum.
Fig 6 :-Pancreas showing the adjacent structure
Fig 7 :-Pancreas and its parts
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Fig 8 :-Pancreas showing surgical important structure
Fig 9 :-Arterial supply of pancreases
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An extensive arterial system originating from multiple sources
supplies the pancreas. Head of the pancreas is supplied by the anterior
& posterior pancreatico-duodenal arteries, which in turn are branches of
superior & inferior pancreatoco-duodenal arteries arising from celiac
axis and superior mesenteric artery respectively.
The blood supply to the body and tail of the pancreas  is 
through splenic and gastroepiploic arteries. Venous drainage
corresponds with the arterial anatomy.
Multiple lymph node groups drain the pancreas. Head is drained 
by, node in pancreatico-duodenal groove, subpyloric, portal, mesocolic,
mesenteric and aortocaval node. Body and tail of pancreas drain to 
retro peritoneal nodes in the splenic hilum or to celiac, aortocaval,
mesocolic, or mesenteric nodes.
20
Fig 10 :-Lymphatic drainage of pancreas
Pancreas has both sympathetic & parasympathetic innervations
immediately to the left of the neck, the tail of the pancreas extend to 
the left of the body into the splenic hilum.
21
HISTOLOGY
Fig 11 :-Endocrine system of pancreas
Two distinct organ system share residence with the human
pancreas, the endocrine system and the exocrine system. The acini and
ductal system constitute the exocrine portion of pancreas. Acinar cell
contain zymozen granules. Acinar cell constitute about 80% of
pancreatic mass. Pancreatic acinar tissue is organized into lobules. The
islets of langerhans are distributed throughout the pancreas. Islet cells
consist of differing cell type. 75% are B cell (producing insulin),
20% A cells (producing glucagon) and the remaining are D cells
(producing somatostatin)
22
Fig 12(A & B) :-MICROSCOPIC VIEW OF PANCREAS
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PHYSIOLOGY OF PANCREAS11
Pancreas plays a vital role in digestion of food in the gut and in glucose
homeostasis. Pancreas has exocrine and endocrine secretion. Exocrine
secretion has two distinct components, enzyme secretion originating
from acinar cells and electrolyte secretion originating from the
centriacinar and intercalated duct cells
 pH-8
 Specific gravity-1.007 to 1.035
 Basal  secretory- 0.2  to  0.3  ml / min
 Enzyme secretion- 6 to 20 mg/day
 Bicarbonate rich fluid- 2.5ltrs/day
Enzyme secretion
The pancreatic juice contains enzymes that are of major
importance in digestion. Its secretion is controlled in part by a reflex 
mechanism and in part by  gastrointestinal  hormone,  secretin  and  
CCK.
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TABLE 1 : PRINCIPAL DIGESTIYE ENZYMES
ENZYMES ACTIVATORS SUBSTRATE
Trypsin Enteropeptidase Protein &polypeptide
Chymotrypsin Trypsin Protein& polypeptide
Elastase Trypsin Elastin
Carboxipeptidase A Trypsin Protein & polypeptides
Carboxipeptidase B Trypsin Protein& polypeptides
Colipase Trypsin Fat droplets
Pancreatic lipase ……. Triglycerides
Cholesteryl ester
hydrolase
…….. Cholesteeyl ester
Pancreatic amylase Cl - Starch
Ribonuclease ……. RNA
Deoxyribonuclease ……. DNA
Phospholipase A2 trypsin phospholipid
Powerful protein spliting enzymes of the pancreatic juice are
secreted as inactive proenzymes. Trypsinogen is converted to the active 
enzymes trypsin by the brush border enzyme enteropeptodase when the
pancreatic juice enter in to duodenum.
Trypsin convert chymotrypsinogens into chymotrypsin and other
proenzyme into enzymes. Trypsin can also active Trypsinogen, 
therefore once some trysin is formed, there is an autocatalytic chain
reaction.
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The potential danger of the release into pancreas of a small
amount of Trypsin is apparent, the resulting chain reaction would 
produce active enzyme that could digest the pancreas. It is therefore
not surprising that the pancreas normally contains a Trypsin inhibitor.
Another enzyme activated by trypsin is phospholipase A2. This
enzyme split a fatty acid of lecithin, forming lysolecithin. Lysolecithin
damages cell membrane. It has been hypothesized that in acute 
pancreatitis phospholipase A2 is activated in pancreatic duct, with the
formation of lysolecithin from the lecithin that is a normal constituent
of bile. This cause disruption of pancreatic tissue and necrosis of
surrounding fat.
Small amount of pancreatic digestive enzymes normally leak
into the circulation, but in acute pancreatitis the circulating level of 
the digestive enzyme rise markedly. Measurement of plasma amylase
or lipase concentration is therefore of value in diagnosing the
disease.
ETIOLOGY
Alcohol intake and biliary tract disease account for majority of the 
cases (90%) Relative frequency depends on the patient population and
prevalence of alcoholism in the population studied. In united states
alcohol abuse is the main cause. In Europe and Asia, gall stone
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associated pancreatitis predominates. Also females are more prone to gall
stone pancreatitis and males for alcohol induced pancreatitis.
CAUSES OF ACUTE PANCREATITIS
OBSTRUCTION
 Choledocholithiasis
 Ampullary or pancreatic tumour
 Worms  or foreign  bodies  obstructing  the  papilla
 Pancreas  divism with  accessory  duct  obstruction
 Choledochocele
 Periampullary  duodenal  diverticula
 Hypertensive sphincter of Oddi
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TOXIN OR DRUGS
TOXIN-Ethylalcohol,methylalcohol, scorpion venom,
organophosphorus insecticides.
Drugs - Azathiaprine and Mercaptopurin, Valproic acid, Estrogens,
Tetracycline, Metronidozole, Nitrofurantoin, Pentamidine, Furosemide,
Sulfonamide, Methyldopa, Cimetidine, Ranitidine, Sulindac,
Didanosine, Acetaminophen, erythromycin, salicylates.
TRAUMA
Accidental     - Blunt trauma to the abdomen
Iatrogenic      - postoperative trauma, ERCP, Endoscopic
sphincterotomy
METABOLIC ABNORMALITIES
 Hyper triglyceridemia
 Hypercalcemia
28
INHERITED CONDITION
INFESTION -
Parasitic- Ascariasis, Clonorchiasis
Viral - Mumps, Rubella, Hepatitis A,B, non-A,non-B, 
Coxsackievirus B, Echo virus, adenovirus,  
cytomegalovirus, varicella,
Epsteinbarr  virus, Human Immunodeficiency  virus.
Bacterial- Mycoplasma, Campylobacter jejuni, 
Mycobacterium tuberculosis, M, avium complex,
Legionella, Leptospirosis.
VASCULAR ABNORMALITIES
ISCHEMIA - Hypoperfusion 
Atherosclerotic 
emboli
VASCULITIS - SLE, PAN, Malignant  hypertension.
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MISCELLANEOUS  CONDITIONS
 Penetrating peptic ulcer
 Crohn’s disease
 Reye’ syndrome, Cystic fibrosis
 Hypothermia
IDIOPATHIC  CAUSE
ETIOPATHOGENESIS
GALL STONE PANCREATITIS
The etiology of gallstone in the pathogenesis of pancreatitis was
first suggested by Opie2. He proposed that acute pancreatitis was
initiated by a stone impacted in the ampulla of vater which resulted in 
the diversion, producing reflex of bile into the pancreatic duct.
Pancreatic injury can be initiated by the migration  of  stone  and  not  
necessarily by  the  impaction  of  stone.
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Additional evidence to support the gallstone migration theory  
comes from cholangiographic studied that demonstrate a common 
channel for CBD and pancreatic duct in up to 90% of pancreas with
a history of gall stone pancreatitis, compared with only a 20-30%
incidence of a common channel in patient with calculus biliary tract
disease and no history of pancreatitis12. Recent experimental evidence
shows that biliary pancreatic reflux is not essential for initiation of
gall stone pancreatitis13.
ALCOHOL
There is undoubtedly an association between alcohol abuse 
and acute pancreatis although the exact mechanism of alcohol related
injury is unknown. Several theories exist
1. Pancreatic parenchyma is injured by pancreatic enzyme
extravasation, facilitated by an increase in pancreatic ductal
permeability, in the face of exocrine hypersecretion and partial
ampullary  obstruction14.
2. Protein pluging of pancreatic duct caused by alcohol may
initiated enzyme extravasation  with  resultant  injury
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3. Transient state of hypertriglyceridemia induced by alcohol
ingestion cause toxic level of free fatty acid produced from
lipolysis of triglycerides which may induced pancreatic injury by
causing acinar cell or capillary endothelial cell injury.
4. Toxicity from acetaldehyde the first stable product of ethanol  
Oxidation15.
HYPERLIPIDEMIAS
Hyperlipidemias alone without alcohol abuse can cause acute
pancreatitis. Primary hyperlipidemias- Ferdrickson’s type I and type V
notable for hypertriglyceridemia and chylomicronemia. Secondary
hyperlipidemias- extraneous estrogen administration, nephritis, and
castration may also be the cause of acute pancreatitis.
HYPERCALCEMIA
Hypercalcemia due to hyperparathyroidism cause acute pancreatitis.
Mechanism involve are:
1. Calcium stimulate pancreatic hypersecretion
2. Calcium induced trypsinogen activation with subsequent
parenchymal auto destruction
3. Calcium associated stone precipitation in the pancreatic duct causing 
ductal
4. Obstruction.
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IDIOPATHIC PANCREATITIS
Recent studies have clarified the etiology of acute pancreatitis in
many patient once classified as having idiopathic pancreatitis. 60% of
these patient were identified to have biliary sludge termed
microlithiasis16,17 (suspension of cholesterol monohydrate crystal or 
calcium bilirubinate granules). cholecystectomy or  endoscopic  
sphincterotomy  prevented  release of pancreatitis in these patients.
PATHOLOGY18
MORPHOLOGY
The morphology of acute pancreatitis necrosis stems directly
from the action of activated pancreatic enzymes that are released into
the pancreatic substance. The basic alternation are :-
1. Proteolytic destruction of pancreatic substance,
2. Necrosis of blood vessels with subsequent hemorrhage
3. Necrosis of fat
4. An accompanying inflammatory reaction. The extent and
predominance of each of these features depend on the duration
and severity of process. In the very early stages, only
interstitial edema is present. Soon after, focal and confluent
area of frank necrosis of endocrine and exocrine tissue are 
found.
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The peritoneal cavity contains a serous and slightly
turbid fluid in which globules of oil can be identified. Foci 
of fat necrosis may be  found  in  any  of  fat  depots
Fig 13 :- Pancreas with the inflammed and necrotic area
HISTOPATHOLOGY
Focal areas of fat necrosis occur in pancreatic and peripancreatic
fat. Following enzyme destruction, adipocytes are transformed into 
shadowy out lines of cell membranes filled with pink, granular 
opaque  precipitates amorphous basophilic calcium precipitates may be
visible with in the necrotic focus. Neutrophillic infiltration and 
interstitial hemorrhage eventually ensure
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Fig 14 :-Histopathology of acute pancreatitis
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PATHOPHYSIOLOGY OF ACUTE PANCREATITIS
Owing to relative inaccessibility of the human pancreas and
complexity of the disease most of the pathophysiological data on the 
mechanism of pancreatic inflammation and necrosis are based on animal
model. Experimental studies in rats using cholene deficient diet and cerulin
infusion suggest that these pancreatitis inducing substance cause a blockade
in the secretion of zymogen granules from individual acinar cells which
results in fusion of zymogen granules with intracellular proenzyme
Trypsinogen yielding active intracellular trypsin which is capable of
cellular auto-digestion19.
Finding of acinar cell zymogen granule enlargement and formation
of large Autophagosomes have been found in human tissues in acute 
pancreatitis
PATHOPHYSIOLOGY OF REGIONAL NECROSIS
Three key factor, acting sequentially account for regional necrosis
1. Inrtaglandular activation of pancreatic enzymes cause pancreatic 
enzyme cause auto digestion.
2. Over stimulation of inflammatoryeffectors cells like macrophages,
polymorphs.
3. Vascular mechanism- ischemia, reperfusion, hemorrhage.
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Intra-acinar activation of proteolytic/lipolytic pancreatic enzymes
particularly trypsin seems to be the initial mechanism that triggers auto
digestion.
Once trypsin is generated in excess, it exhausts pancreatic
secretory trypsin inhibitors in the acinar cell and non- specific antiprotease
[alfa2 – macroglobulin] in the interstitium. Free trypsin then activates
other zymogen and several cascade system of protease[ complement
system, kallikreun- kinin, coagulation and fibrinolysis]
Activation of complement system by trypsin and subsequent 
generation of C5a play a major role in the recruitment of inflammatory
cells. Over stimulation of macrophages and neutrophils results in the local
spilling of arachidonic acid metabolites, proteolytic and lipolytic enzymes,
clot promoting factors, platelet-activating factor and cytokines, which
exceed the scavenging capacity of endogenous antioxidant systems. These
substances interact with pancreatic microcirculation to produce thrombosis
and hemorrhage.
Local circulatory effects play a significant role in the extension
and complication of pancreatic necrosis. Endothelial cell damage and  
local activation of the coagulation system by trypsin results in interstitial
edema and fibrin- platelet thrombus formation in the pancreatic
microcirculation. The subsequent pancreatic ischemia result in reduction in
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local and regional input if antiproteases  and  amplifies  the  premature  
activation  of  trypsinogen.
This cascade of multiple activation of enzymes leads to the rapid
exacerbation of the inflammatory process and to the gradual widening 
of regional  necrosis.
Fig 15 :- Pathophysiology of acute pancreatitis
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PAHTOPHYSIOLOGY OF REMOTE ORGAN DYSFUNCTION
The clinical course of acute pancreatitis can be divided into two
successive phase.
1. The early ‘Toxemic’ phase (0-15 days) characterized by distant
organ damage leading to multi organ failure.
2. The late ‘Necrotic’ phase [after 2nd       week] characterized by
locoregional complications.
The systemic complication that characterize the early stage of
the attack, particularly cardiocirculatory and respiratory failure, are
mainly due to spilling of active pancreatic enzyme and toxic 
substance from the retro peritoneum into systemiccirculation. The 
route of autointoxication is mainly through retroperitoneal and
peripancreatic lymphatics, which drain into the thoracic duct.
The homodynamic profile of early phase is characterized by
low systemic vascular resistance, increased cardiac output, oxygen
uptake, pulmonary shunt  fraction  and  severe myocardial depression.
These changes are attributed to
1. Intravascular volume depletion because of increased vascular
permeability, abnormal fluid sequestration and gastrointestinal or
retro peritoneal hemorrhage.
39
2. Direct  or  trypsin  mediated  activation  of  contact  system
3. Release of myocardial depressant factor by acinar cells
4. Release of prostanoids and cytokines notably tumor necrosis
factor by activated leucocytes.
The homodynamic response is similar to gram-negative sepsis,
which includes increased resting energy expenditure, elevated protein
catabolism, hepatic  gluconeogenesis  and  peripheral insulin resistance.
Respiratory complication arises from combination of pleural
effusion, elevated diaphragm to pain/ ileus, atelectasis, hypoxemia and
pulmonary infection. About 20% suffer from early ARDS, the cause
being damage and subsequent increased permeability of alveolar 
capillary membrane. Other mediators of ARDS are pulmonary
leucostasis, proteolytic enzymes [elastase]. Phospolipase A2
hypertriglyceridemia and activated coagulation system by trypsin.
Other causes of respiratory failure are pulmonary embolism, aspiration 
and nosocomial pneumonia.
Pleural effusion found in acute pancreatitis are due to transfer of
peripancreatic exudates via the peri- diaphragmatic  lymphatic plexus
DIC results from photolytic effects of circulation trypsin.
Oliguria and renal failure are due to hypovolemia, deposition of fibrin
in the glomerular capillaries  and  acute tubular necrosis.
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PATHOPHYSIOLOGY OF LOCAL COMPLICATION
Pancreatic phlegmon refers to edematous, inflammatory and 
necrotic sterile tissue in and around the pancreas. The necrotic tissue
gets infected (infected peripancreatic collection) in about 40% of
patient, more so in gall stone pancreatitis. The risk of pancreatic sepsis
is maximum in the third week. Early infection is mostly by a 
single gram negative organism GIT origin by translocation,
perforation, infected bile or post ERCP or via hematogenous or
lymphatic spread. Infected pancreatic necrosis in which necrotic tissue
predominates  present  early  and  has  higher  mortality.
Pancreatic abscess consists of pus enclosed by inflammatory
walls resulting from infection of liquefied necrotic areas. Pancreatic
abscess present after the active phase is over and run a more indolent
course with fewer complications.
Pancreatic pseudocyst develops in 10-20% of patient and is 
more common in alcoholic pancreatic complication, though sepsis and
hemorrhage are more likely in cysts associated with gallstone. Acute
pseudocyst consist of an effusion of pancreatic Juice rich in amylase
that lacks in epithelial lining and has become gradually enclosed by
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fibrosis walls after a period of 4-6 weeks21. Half of the pseudo cyst
resolve spontaneous in 1-2 month, some of them fistulise into the
peritoneal cavity ( pancreatic ascites) or into chest( pancreatico- pleural
or pericardial fistula) where secondary infection or bleeding can
occur.
Gastrointestinal and retroperitoneal hemorrhage can occur due to
gastric ulcers, esophageal varices,  erosion of visceral vessels and
pseudo aneurysm.
Coloniccomplication include mechanical obstruction, rectal bleeding,
and colonic necrosis with perforation and fistula formation. Colonic
damage is attributed to direct toxic effect of pancreatic enzymes
(pericolitis) or colonic vascular ischemia (due to DIC, thrombosis of 
superior mesenteric vein, hypotension)
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CLINICAL PRESENTATION OF ACUTE PANCREATITIS
A reasonably secure diagnosis is often possible based solely on
clinical presentation. In more than 90% of patients the predominant
features is pain abdomen. Pain is mostly in the epigastrium, constant,
boring or penetrating and may radiate to the back. Pain start 12-48
hour a bout of alcohol or after a large meal in case of gallstone
pancreatitis. Fever,  vomiting, tachycardia, epigastric tenderness,
hypoactive and absence bowel sound, and abdominal distension are
other feature. Some times a mass can be palpable in the epigastrium. In
about 3% patient, hemorrhagic panceatitis can cause bluish 
discoloration in the left flank (Grey Turner’ sign) or around the
umbilicus(Cullen’s sign). These signs, are due to tracking of blood 
stained retroperitoneal fluid planes of abdominal wall to the flank or
along the falciform ligament to the umbilical area, and indicate severe 
episode of acute pancreatitis22. Jaundice may be present and
represent distal common bile duct obstruction by a gallstone or
compression by pancreatic edema. In severe acute pancreatitis
hypovolemia, hypotension, hypo perfusion  and  obtundation  may  be 
present
Other manifestations include pleural effusion (mostly left side),
ascites, and elevation of left hemi- diaphragm with tachypnoea,
dyspnoea and cynosis. Less commonly subcutaneous fat necrosis,
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cerebral abnormalities of a non- lateralizing nature and disseminated
intravascular coagulation can be seen.
DIAGNOSTIC WORK UP
The direct inspection of pancreas at laparotomy with
microscopic examination of pancreatic tissue is only way to confirm 
the diagnosis of the acute pancreatits. In routine clinical practice,
clinical feature particularly pain abdomen, nausea/ vomiting and
raised serum amylase are the diagnostic cornerstone. The elevation of 
serum amylase (normal 60-180U/L) is observed within 24 hours of
the onset of symptoms and gradually return to normal in the
subsequent weeks. Persitent elevated serum amylase beyond initial 
week of illness reflect ongoing pancreatic inflammation or development
of pancreatic complication, pseudocyst, phlegmon or abscess. Serum   
amylase  determination has high sensitivity(>95%8,23) but over all 
specificity is low (70%), since elevated serum level occur in many
condition( intra abdominal and extra abdominal).
Furthermore, amylase level is not raised in 5% of cases being
hyperlipidemic pancreatitis, extensive pancreatic necrosis, and
chronically diseased  pancreas.
Improved accuracy in diagnosis of acute pancreatic can be
achieved by measuring amylase isoenzyme component. P-type
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isoenzyme, which arises from pancreas account for 40% total 
circulatory amylase, is raised out of proportion in acute pancreatitis,
peptic ulcer perforation, bowel obstruction and mesenteric infarction. S-
type isoenzyme is seen in ruptured ectopic pregnancy, salivary gland
disorder and salphingitis etc.
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TABLE 2: DISORDERS ASSOCIATED WITH HYPERAMYLASEMIE
INTRA-ABDOMINAL EXTRA-ABDOMINAL
Pancreatic disorders 
Acute  
pancreatitis 
Chronic  
pancreatitis 
Trauma
Carcinoma
Pseudocyst 
Pancreatic
ascites Abscess
Non  pancreatic  
disorders Biliary  tract  
disease Intestinal
obstruction 
Mesenteric infarction 
Perforated  peptic  
ulcer Peritonitis
Afferent loop
syndrome Acute  
Salivary  gland  disorders
Mum
ps
Paroti
tis 
Trau
ma
Calcu
li
Impaired  amylase 
excretion Renal  failure
Macroamylasemia
Miscellaneous
Pancreatic pleural
effusion Pneumonia
Mediastinal pseudocyst
DKE (Diabetic Keto
acidosis) Pregnancy
Urinary amylase excretion (normal 4-400 U/L) is more
sensitive index of acute pancreatitis though not diagnostic.
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Amylase–creatinine clearance ratio has been used in the
diagnosis of acute pancreatitis. This is calculated by the equation.
Urine amylase/serum amylase X serum creatinine/urine creatinine
The ratio varies from 1-5%. A ratio more than 6% is
consistant with the diagnosis of acute pancreatitis. This is also
disfavoured because the amylase creatinine clearance ratio may be
raised in diabetic ketoacidosis, burns, renal insufficiency, perforated  
peptic  ulcer, pancreatic  carcinoma, etc.
Serum lipase elevation is a more specific indicator of acute 
pancreatitis than serum amylase because lipase circulating in the serum 
is mostly of pancreatic Origin8 Lipase is elevated for longer period
and hence useful in patient who present late. But, serum lipase is
not most specific for acute pancreatitis, as it can be raised in
perforated peptic ulcer, acute cholecystitis and  intestinal  ischemia.
Diagnostic paracentesis and analysis of peritoneal fluid for 
elevated amylase and lipase combined with serum elevation of the 
same has been strongly correlate with acute pancreatitis. Serum 
latescence is another indicator of acute pancreatitis due to 
hyperlipidemia and alcohol. Methemalbumenemia has been suggested
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as a marker for acute hemorrhagic pancreatitis but it lacks sensitivity  or  
specificity.
Hemoconcentration, leucocytosis, hyperglycemia, hypocalcemia,
mild azotemia hyperbilirubinemia, elevation of ALT, ALP and GTT,
coagulation abnormalities marked by hyper coagulability,
hypofibrinogenemia and DIC are other hematological changes seen in
acute pancreatitis.
RADIOLOGICAL PROCEDURE
Plain radiograph of the abdomen may reveal paralytic ileus,
increased gastro colic separation, sentinel loop ( dilated proximal
jejunal), colon cut-off sign( distension of colon at the level of transverse
colon with no gas in splenic flexure); cholelithiasis, obliteration  of psoas  
margins23.
Plane radiograph also rules out potential abdominal emergencies
like perforation of hollow viscous or mesenteric ischemia.
A chest radiograph may show left pleural effusion, elevated left
hemi diaphragm, basal atelectasis and also delineates other causes of 
plain abdomen like left lower lobe pneumonia or pneumoperitoneum.
In multiorgan failure if lung  is  affected ARDS  changes are seen on
chest X –ray.
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Upper GI contrast studies may show widening of ‘C’ loop of
duodenum, anterior displacement of stomach and duodenal mucosal
abnormalities, but  are  not  longer  favored as these finding are not
specific.
Abdominal ultrasound examination cab be inconclusive and often
misleading. It is largely operator dependant and in 30-40% of patient’s
pancreas cannot be visualized due to air filled bowel loops. It is the
also inaccurate in detecting pancreatic necrosis and regional inflection.
Still, it can be used to detect pancreatic edema, peripancreatic fluid
collection, gallstone causing pancreatitis, biliary  sludge  and  also  
pseudocyst, ascites, portal or splenic vein thrombosis.
CT scan is currently the most sensitive non invasive method to
confirm the diagnosis for acute pancreatitis26. The specificity of an
admission CT scan is found 100% and sensitivity is 85%. Most
episodes undetected by CT scan are mild and CT scan also provides
alternate diagnosis in case with false positive elevation of enzymes.
Also contrast enhancement differentiates between edematous  and  
necrotizing  pancreatitis.
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CT FINDING IN ACUTE PANCREATITIS
PANCREATIC CHANGES
 Parenchymal  enlargement-diffuse, focal
 Parenchymal  edema
 Necrosis
PERIPANCREATIC CHANGES;
 Blurring of fat planes
 Thickening of fascial planes
 Presence  of fluid  collection
NON- SPECIFIC SIGNS
 Pleural  effusion
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 Bowel  distention
 Mesenteric edema
CT scan is also useful in demonstrating structural complication
that develop during the course of acute pancreatitis like pancreatic
abscess, pseudocyst or fluid collection. Also severity of acute
pancreatitis can be graded using CT scan and has been used in
prediction of prognosis 9,27,28,29.
MRI provides a more accurate diagnosis of acute pancreatitis
and equivalent information, as CT scan, about  extent of fluid collection
and parenchymal irregularities.
ERCP should be done only in patient with acute pancreatitis who
clinical, course fail to improve despite full intensive care support 
and in whom ampullary or common bile duct stone impaction is 
suspected based on ultrasound or clinical/ biochemical sign of
cholangitis. Risk of exacerbation of pancreatitis, introducing infection
into devitalized pancreatic area, failure of pancreatic catheterization due
to duodenal stenosis by pancreatic swelling and papillary  edema  limit  
the  use of  ERCP in the early stages of pancreatitis.
However , ERCP may be more useful in patient who have
recurrent attacks of acute pancreatitis without an obvious etiology. It
is useful in identifying potentially correctable lesion such as CBD
stones with impaction, pancreas divisum, ampullary stenosis etc where
appropriate intervention can prevent recurrent pancreatitis in more  
than  80% of  patient.
Studied have shown that early endoscopic sphincterotomy
improves prognosis in patient with gall stone pancreatitis with jaundice
and cholangitis30,31,32,33,34,35
Fig 16(a):- USG showing Acute Pancreatitis
Fig 16(b):
PROGNOSTIC STRATIFICATION
Early assessment
importance to avoid
largest group of patient,
prediction of severity
intensive care unit 
aggressive treatment
MULTIFACTOR SCORING SYSTEM
One of the early 
by Ranson in 1936.
and six additional criteria
criteria were refined
- CECT showing Acute Pancreatitis
and prediction of severity are of 
costly and invasive monitoring and treating
who tend to turn a benign course.
and monitoring are necessary in severe
to anticipate early and complication to 
and to judge the response to therapy
system for judging severity was 
it incorporates five feature measured at
Determined during the initial 48
to create two similar systems, one for
outstanding  
in the
Accurate
form in an 
consider 
developed 
admission
hours. The
alcoholic
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pancreatitis and for gallstone pancreatitis. Patient with zero to two 
Ranson prognostic sign have essentially no mortality and do not
require anything more than simple supportive care. Patient with three
or four signs have a mortality of 15% and 40% of these patient
require intensive care therapy.
Patient with five or six signs have a mortality rate of
approximately 50% and almost universally require support in an 
intensive care unit. Patient with seven or more prognostic signs
have a predicted mortality of almost 100%.
RANSON’S CRITERIA36
ALCOHOLIC PANCREATITIS
on admission to hospital
 Age  >55 years
 White blood count> 16000/mm3
 Glucose> 200mg/dl
 Lactate dehydrogenage > 350 U/L
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 Aspartate  aminotransferase>250 U/L
within 48 hours of admission
 Decrease in hemotocrit >10 %
 Increase in blood urea  nitrogen > 5 mg/ dl
 Serum calcium < 8 mg / dl
 Arterial oxygen pressure< 60mm Hg
 Base  deficit  >4mmol/Ltr
 Fluid  sequestration> 6Ltr

GALLSTONE PANCREATITIS
On admission to hospital
 Age >70 year
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 White blood count>18,000
 Glucose >220 mg/dl
 Lactate dehydrogenase>400U/L
 Aspartate  aminotransferase>250U/L
Within 48 hours of 
admission
 Decrease in hematocrit >10 %
 Increase in blood urea nitrogen>2mg/dl
 Serum calcium<8mg/dl
 Fluid  sequestration>4l
 Base  deficit>5mmol/l
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Further modification of this system in Glasgow by Imrie and
his colleagues in 1978 led to the Glasgow system where only 9 factor
need to be assessed37. A further refinement of this system by Blamey
and Imrie in 1984 led to  Modified  Glasgow  system where only 8
factor need to be assessed38.
MODIFIED GLASGOW CRITERIA38
within 48  hours  of  
admission
 Age >55 years
 White blood cell count>15000/mm3
 Glucose> 180mg/dl
 Blood  urea  nitrogen> 45 mg/dl
 Lactate dehydrogenase > 600U/L
 Albumin< 3.2gm/ dl
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 Arterial oxygen pressure < 60mm Hg
 Serum calcium <8 mg/dl
Despite refinement, the above scoring system were found to have 
low sensitivity and specificity33,40. Which has reduced the practical
value of these scoring  system for  the  early  assessment  of acute
pancreatitis.
Another shortcoming with Ranson’s is its inability to be used 
after 48 hours of admission and since acute pancreatitis is a
dynamic process where repeated assessment of the patient is most
desirable, Ranson’s criteria are not helpful Other  illness  scores,  
which  are  used  to  qualify the severity of acute illness in intensive
care units, have been used in acute pancreatitis with more
efficacy than  Ranson or  Glasgow’s  criteria.  They  are:
 Simplified  acute  physiological  score (SAPS)
 Acute  physiological  and  chronic health evaluation score 
(APACHE II)
 Medical Research Council Sepsis score (MRCS)
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CT STAGING
The value of CT scan as an early predictive indicator of morbidity
and mortality was first established by Sielgelmen et al in 1980 and 
Hill et al in 1982.
Balthazar in 1989 graded patient with acute pancreatitis into
five categories based on CT scan finding9. He showed that patients
without peripancreatic inflammation (grade A&B) have a mild
uncomplicated course while those with one or more peripancreatic 
collection (grade D&E) often exhibit a protracted clinical illness with a
higher frequency of complication and death.
TABLE 3:  CLASSIFICATION OF  TYPE AND SEVERITY OF
PANCREATIC INFLAMMATION  BASED  ON  CT  SCAN
(BALTHAZAR 1989)9
GRAD A Normal  pancreas
GRAD
E
B Restricted intraglandular changes with out evidence of
peripancreatic disease, including non homogenous  
attenuation of the gland, contour irregularities,
intrapancreatic foci of small fluid collections and  
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GRAD
E
C Intrinsic pancreatic abnormalities associated with 
inflammation of  peripancreatic  fat  giving  it a hazy
GRAD
E
D Single poorly defined extra pancreatic fluid collection 
or phlegmon
GRAD
E
E Two  or  more  ill- define  extra  pancreatic  
collection  or the presence of gas in or adjacent to
Another prospective study by the same author evaluated the
prognostic significance of pancreatic necrosis as detected by CT
scan.
The positive predictive value for development of pancreatic
abscess was 84% in patient with necrosis and phlegmon ( grade D&E)
, 77% in patient with necrosis  alone  and  46%  in  patient  with  
phlegmon  alone.
Other conclusion of this study were firstly, the degree of early 
necrosis does not seem to be of prognostic value and secondly late 
necrosis appearing during follow up signifies poor prognosis in patient
with initially normal pancreatic enhancement.
This stressed the utility of follow up CT scan every 2 weeks in 
patient with peripancreatic phlegmons 29
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In another study comparing CT scan and APACHE II scoring, CT 
scan criteria best defined local anatomical abnormality and was found 
to be superior to APACHE II score as predictor of local complication,
but CT criteria were inferior to APACHE II as indicators of systemic
disease severity (as reflected in the need for ICU admission). The
most effective initial triage would be APACHE II Calculation
Drawback of CT scan are the expenses, limited availability,
limited specificity and inconvenience for several ill patient.
Rebeneck clinical prognostic staging system using clinical
feature and comorbid illness is easy to use and requires no special
or additional tests.
TABLE 4: Clinical Severity of Acute Pancreatitis with
Comorbidity
Clinical Severity of Acute 
Comorbidity41
Non Sever
No Ileus or Peritonitis I II
Ileus or Peritonitis II III
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Complication  or  death  occurred  in 7%  of  patient  in   stage
I, 40%  of patient  in stage II, and 67% of patient in stage III.
Agarawal and Pitchumoni outline clinical assessment for severity
stratification in which the main adverse criteria are 1-high quantity
fluid requirement( 5 liters or more per day for the first two days) to 
maintain hemodynamic stability 2- early organ dysfunction, especially 
renal and pulmonary42.
Recently Imrie and his colleagues have questioned the Atlanta
classification system where in all patient with organ dysfunction are
classified as having severe acute pancreatitis. They suggested that 
only patients with worsening organ dysfunction should be classified as
having severe acute pancreatitis and they found that dynamic nature
of early organ dysfunction is a predictor of acute  pancreatitis.
SINGLE PROGNOSTIC FACTOR
Several clinical sign, biochemical marker and imaging
procedure have emerged in an attempt at early identification of 
pancreatic necrosis, monitoring of its progression and assessment of  
the  response  to  therapy.
In particular C- reactive protein, leucocyte elastase typsinogen
activation peptide44 and inter leukin-6 have shown promise as simple
marker of disease severity.
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Recently serum procalcitonin, a marker of systemic
inflammation has been found to have sensitivity of 92% and
specificity 84% at 24 hrs from onset of acute pancreatitis for
predicting severity48. Another factor activation peptide of 
carboxypeptidase B in urine has been found to have sensitivity of
92% and  specificity  of 89%  for  predicting severity  of acute  
pancreatitis46
THE APACHE SYSTEM
Acute physiological and chronic health evaluation.
The first major attempt at a system to quantity severity of 
illness in ICU patient  was  the  APACHE  system,  by Knaus et  al  in  
198147.
APACHE I:
In original form, APACHE contained 34 physiological
measurement and included many continuous variables. A value of 0-4
was assigned to each variable, according to its degree of abnormality.
Shortly after its introduction APACHE I system was disfavored,
because of practical problem like collection of large number of
variable. Also under the rule of APACHE system any unmeasured
variable was assumed to be normal and weighted as zero. This gave rise
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to question about the model general applicability. Another major
criticism of original APACHE system was that the variables were
chosen by a group of physician and hence there was potential of 
bias. These inaccuracies in the original APACHE system prevented
its widespread use. However, it did serve as a prototype  for  the  
development of  two  subsequent systems.
SAPS:
The simplified acute physiological score was developed from 
APACHE I system and incorporated 13 variable that had the most 
discriminate power and  were  the  most  frequently  measure  
variables  to  cover  all  major  organ system. SAPS score is still used 
but has essentially been replaced by APACHE II  in many  centers.
APACHE II
Published in 1985 by the same author this is the second version of
the APACHE system and it contain refinement based on experience
with the original APACHE system. APACHEII has been extensively
used and has received for more attention in the literature than any 
of the other methodologies for ICU Out comes prediction. It contain 12
continuous variables from the original APACHE system and also
takes into account age of the patient,  pre- morbid condition and
Glasgow coma scale.
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DEVELOPMENT OF APACHE II :
Using clinical judgment and documented physiological
relationship to choose variables and assign weight remains the essence
of APACHE II. The number of variables was reduced from 14 to 12.
Infrequently measured variables such as serum osmolality, lactic acid
level, and the skin testing for energy were deleted. Serum BUN was
replaced by more specific serum creatinine and serum pH was
retained in preference to bicarbonate. Many variables crucial in patient 
care, such as serum glucose, albumin, CVP and urinary output were
found to have less explanatory power. Most of these variables were
sensitive to variation in therapeutic decision than severity of disease.
Some of the threshold and weight for the physiology variables
have been changed e.g. Glasgow coma  score, serum creatinine. Also 
since alveolar- arterial O2 gradient(p [A-a] O2) is heavily dependent 
on inspired O2 (F1 O2) a direct weighting was given to all paO2
values when FiO2   is  less  than  0.5
To eliminate the problem of missing values and concerns about 
the assumption that an unmeasured variables was normal, measurement
of all 12 variables was made mandatory for usage of APACHE II. 
The recorded value of the variables are based on the most deranged
values during the past 24 hours.
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Because age and severe chronic health problem reflect
diminished physiological reserve, they have been directly incorporated 
into APACHE II. also, emergency surgery and non operative patient
with severe chronic organ system dysfunction were given additional five
points in comparisons to elective surgical patient who were given only
two points because patient with severe chronic condition are not
considered to be candidates for elective surgery.
The maximum possible APACHE II score is 71. in the
experience of the author of APACHE II no patient  had exceed 55.
The strengths of APACHE II system are
1. It has a well- define outcome (hospital death)
2. It was  derived  from a  database (5815 patient from 13 hospital)
3. Source of bias present in its prototype was understood and
corrected.
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SHORT COMINGS OF APACHE II SYSTEM
Because of extensive usage, important sources of error and bias in
the APACHE II system were revealed. First, APACHE II perform well
over all in several ICU population but it is inaccurate when looking at
specific disease categories because the data base from which it was 
derived, though large, did not contain many patient in major disease
subsets such as cardiac surgery, oncology etc. second, APACHE II
dose not accounts for prior treatment or clinical course before the
patient enter ICU, this has been labeled as lead- time bias. Third, 
APACHE II require determination of a single admission diagnosis,
a subjective process prone to bias. Finally despite reduction in number of
variables, measurement error from bedside data  collection  is  still on  
issue.
APACHE II has been recently refined into APACHE O, where O
represents Obesity, and this is a better prognosis than APACHE II48
. another modification of APACHE II is the APACHE III system,
which is yet to be applied widely to acute  pancreatitis clinical  
trial49.
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ATLANTA CLASSIFICATION7
An international symposium was conducted in Sep 11 through 
13, 1982, and a unanimous consensus on a series of definition and a
clinically based classification system for acute pancreatitis was 
achieved by a diverse group of 40 international authorities from 
six medical disciplines and 15 countries. The proposed classification
system is of value to practicing clinicians in the care of individual
patient  and  to  academicians  seeking to compare inter institutional  data.
The Atlanta symposium defined terms like acute pancreatitis
(severe and mild), acute fluid collection, necrosis, pseudocyst and
abscess. The symposium also discarded term like phelgmon, infected 
pseudocyst and hemorrhagic pancreatitis.
The present study makes use of these definition while
predicting the patient out come.
DEFINITION
ACUTE PANCREATITIS
Acute pancreatitis is an inflammatory process of the pancreas,
with variable  involvement  of  other  regional  tissue  or  remote  organ 
system.
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SEVERE ACUTE PANCREATITIS
Severe acute pancreatitis is associated with organ failure and/ or
local complication, such as necrosis, abscess or pseudocyst. This is 
characterized by three or more Ranson criteria or eight  or  more
APACHE  II  points.
MILD ACUTE PANCREATITIS
Mild acute pancreatitis is associated with minimal organ 
dysfunction and an uneventful recovery, and it lacks the described 
feature of severe acute pancreatitis.
ACUTE FLUID COLLECTIONS
Acute fluid collection occur early in the course of acute
pancreatitis, are located in or near the pancreas, and always lack a wall
of granulation or fibrous tissue
PANCREATIC NECROSIS
Pancreatic necrosis is a diffuse or focal area (s) of nonviable
pancreatic parenchyma, which is typically associated  with  
peripancreatic  fat  necrosis.
ACUTE PSEUDOCYST
A pseudocyst is a collection of pancreatic juice enclosed by a
wall of fibrous or granulation tissue, which arise as a consequence of
acute pancreatitis, pancreatic trauma, or chronic pancreatitis.
PANCREATIC ABSCESS
64
A pancreratic abscess is a circumscribed intra-abdominal
collection of pus, usually in proximal to the pancreas, containing little 
or no pancreatic necrosis, which  arises  as  a  consequence  of  acute
pancreatitis or pancreatic trauma.
Phlegmon, infected pseudocyst, hemorrhagic pancreatitis and
persistent acute pancreatitis are nonspecific terms in general usage,
these should be discarded and specific terms as defined above
should be used.
TREATMENT OF ACUTE PANCREATITIS
MEDICAL TREATMENT
Treatment of acute pancreatitis is primarily conservative. Basic
medical therapy of acute pancreatitis includes withholding of oral
feeding, nasogastric suction for paralytic ileus, and correction of fluid,
acid base disorders, electrolytes and vigorous volume replacement. Non
morphine based analgesia and sedative are often required for pain. In
mild acute pancreatiits, antibiotics require only if disease is due to 
biliary stones, with attendant possibility of bile infection in more
than 50% cases50. Early antibiotics prophylaxis is strongly advocated in
acute necrotizing pancreatitis as the initial sterile necrosed tissue is
vulnerable to infection because of its avascularity and the acute
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catabolic infection. The incidence of  infection is 20% in first week,
40% in second weeks and 60% in third weeks. Infection dramatically
worsens the prognosis, with a mortality ranging from 20% to 50%.
Currently, majorities of death in necrotizing pancreatitis are
associated with infection51. The organism  responsible for infection
traverse by translocation from intact gut and are the enteric flora
mostly coliform, with 20%-30% anaerobes.
Imipenem is the antibiotic of choice, as ( i) it has the maximum
blood- pancreas diffusion, and (ii) it has widest spectrum against
organism of enteric flora, including  anaerobes52. However , the  cost  
factor  may force  the  use  of quinolones as the next best choice in
combination with an anti- anaerobe.
Various well define studied have failed to demonstrate any
impact on outcome of the disease with the use if somatostatin
derivative of octreotide, however few smaller studies53 have shown a
trend towards decrease in complications.
Aggressive nutritional support should be initiated either as  
total parenteral nutrition or alternatively, early  elemental jejunal feeds 
can  be instituted to preserve or restore mucosal barrier and gain
immune therapeutic benefit.
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Therapeutic cytokine manipulation using anti TNF antiserum,
CNI-1493 and AF antagonist Lexipafant54 are under clinical trials and
have been shown to decrease the severity of acute pancreatitis and
reduced the incidence of multiorgan system failure. A therapeutic
window, 12- 36 hours after onset if pain, has bees shown to exist
allowing for the antagonism of cytokines during clinical  pancreatitis.
It is a known fact that the only definitive treatment of a 
patient with acute pancreatitis in the initial 72 hrs is massive fluid
transfusion to maintain hemodynamic stability6. All other modes of 
treatment offered to the patient from nasogastric aspiration to 
surgery have been debated and their effectiveness has been
questioned55,56,57.
Massive 3rd   space fluid loss may be primarily responsible
for tissue anoxia, its may aggravate already existing cellular anoxia
further.
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PROPOSED NONOPERATIVE THERAPIES FOR ACUTE
PANCREATITIS
SUPPORTIVE MEASURES
 Intravenous fluid therapy
 Electrolyte replacement
 Analgesia
 Nutritional support
 Antibiotics
 Respiratory support
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PANCREATIC EXOCRINE SECRETION SUPPRESSION
 Nasogastric suction
 Hitamine ((H2) receptors  antagonists
 Antacids
 Anticholinergies
 Glucagon calcitonin
 Somatostatin
 Peptide YY
 Cholecystokine  receprors antagonists
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PANCREATIC ENZYME INHIBITION
Protease inhibitors:
 Aprotitin
 Gabexate
 Camostae
Fresh frozen plasma
Antifibrinolytic
Chloroquine 
PhaspholipaseA 
inhibitors
PANCREATIC PROTECTION FROM OXYGEN DERIVED FREE
RADICALS
 Free  radicals  scavengers
 Xanthine oxidase inhibitors
 Isovolemic  hemodilution
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EXAMINATION OF TOXIN INTRAPERITONEAL COMPOUNDS
Peritoneal dialysis
PLATELET- ACTIVATION FACTOR ANTAGONISTS
Lexipafant
SURGICAL TREATMENT
Indication for  operative  management  in patient with  severe  acute  
pancreatitis58
 Persisting  acute  abdomen
 Infected necrosis
 Sterile necrosis causing MODS syndrome ( not responding to 
maximum ICU  measures  for  more than  72  hours)
 Correction of associated biliary  tract  disease
 Persisting and increasing  local complications
 Pancreatic  abscess
 Pseudocyst
 Gastrointestinal  fistula
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TABLE 4: ATLANTA CLASSIFICATION AND ITS 
MANAGEMENT
ATLANTA TREATMENT PRINCIPLES
Interstitial- edematous
pancreatitis (mild AP)
Non  surgical
Necrotizing pancreatitis (severe
AP)
 STERILE necrosis
 Infected  necrosis
Non surgical ,surgical if non
Surgical debridement+continuous
lavage and open  packing
Pancreatic  abscess Interventional drainage, in case of
persisting sepsis- surgical drainage
Acute  pseudocyst Interventional drainage, surgical 
drainage is second  choice.
Fig 17:- Intraoperative Pancreatic Pseudocyst
Fig 18:- CECT – Pancreatic Psudocyst
Fig 19:- USG – Pancreatic Psudocyst
Fig 20:- CECT – Pancreatic necrosis
Fig 21(a):- Intra Operative- Pancreatic Necrosis
Fig 21(b):- Specimen showing Pancreatic
Necrosis
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UNCERTAINTY OF CLINICAL DIAGNOSIS
Because no single test or combination of studies can enable
one to diagnosed acute pancreatitis with 100% accuracy, it may
occasionally be difficult to exclude other diagnoses that mimic acute
pancreatitis and require operative intervention example of such condition
include perforation viscus and acute mesenteric ischemia. In these
situation when the clinical diagnosis not confirm, exploratory
laparotomy or diagnostic laparoscopic may be indicated to exclude a
surgically correctable disease with a potentially fatal outcome in the 
unoperated state. If uncomplicated acute pancreatitis is present, no
manipulation is indicated, and the operation is terminated. In patient
with cholelithiasis and presumed gallstone- associated pancreatitis,
definitive biliary surgery, is favored if the clinical circumstances
permit. In patient with severe necrotizing pancreatitis without frank
infection, formal pancreatic resection is not favored. Instead, caution
debridement of necrotic tissue is performed, and wide retroperitoneal
drainage is considered.
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TREATMENT OF SECONDARY PANCREATIC INFECTION
Pancreatic abscess, infected pancreatic pseudocyst, and infected
pancreatic necrosis are three life threatening complication of acute 
pancreatitis that occur in up to 5% of all patient. By definition,
pancreatic abscess and infected pancreatic pseudocyst are associated with
little or no necrosis. The combination of abdominal USG/CT scan and
guided percutaneous needle aspiration (and bacteriology) of fluid (from
three different areas to avoid sampling error) has been demonstrated
to be highly reliable in differentiating a pancreatic infectious process 
from a sterile necrotic collection59. Treatment of secondary pancreatic
infection combines antibiotic therapy with prompt drainage. Operative
debridement is usually necessary to remove the thick, debris- filled.
Paste like collection of infected necrotic materials in patient with
infected pancreatic necrosis. The two currently acceptedoperative
management of infected pancreatic necrosis and some pancreatic abscess
are
1. Laparotomy with  debridement  and  wide  sump  drainage, and
2. Laparotomy with debridement, open packing, and scheduled
repacking5,60.
A recent technical is “closed laparostoma” this is a semi-
open method of temporary closure of abdomen with zipper, Gortex,
77
Marlex or Nylon61 in order to avoid very frequent scheduled
reoperation and to reduce loss of fluid, electrolyte and protein
associated with open packing. In both these method relaparotomy and
redebridement are carried out until the progressive necrotic process is
controlled and no further infection/ necrosis is evident.
Recently peripancreatic necrosis collection has been treated by
retroperitoneal route using endoscopic techniques62. With encouraging
preliminary result. However this approach is not exclusive and may be
combined with a secondary laparotomy when needed.
CORRECTION OF ASSOCIATED BILIARY TRACT DISEASE
Formerly, definitive biliary tract operation for gallstone -
associated pancreatitis were often deferred up to 8 weeks after the
acute episode of pancreatitis. This approach gradually lost favour, 
primarily because of the advent of laparoscopioc cholecystectomy and
because the natural history of gall- stone associated pancreatitis without
surgical intervention is that of frequent recurrence. Because most episode
of gallstone- associated pancreatitis followed a mild, short lived clinical
course, and because definitive biliary tract operation at the time of 
the index admission have proved safe and cost effective, early
biliary tract procedure are now favored in most patient. Most surgeon
proceed with laparoscopic cholecystectomy, after clinical resolution
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of pancreatitis and normalization  of  the  liver function test.
Fig 22:- Laparoscopic Cholecystectomy
Three exception to this treatment algorithm for gallstone pancreatitis
are
1. Gallstone  pancreatitis  and  either jaundice or cholangitis
2. Severe  acute  pancreatitis
3. Patient who refuse surgery or are at extraordinary high risk 
for elective cholecyctectomy.
Patients with severe acute pancreatitis, especially those with
obstructive jaundice or cholangitis, the currently recommended
treatment includes urgent ERCP and sphincterotomy. Studied have 
79
shown that patient with predicted severe pancreatitis are more likely to
benefit from endoscopic intervention that those with predicated mild
pancreatitis30,31,32,33,34,35.
TREATMENT OF COMPLICATIONS
Pancreatic abscess is encountered less frequent than infected
pancreatic necrosis. Currently, the treatment of choice is percutaneous
USG/CT guided aspiration and drainage by one or more pigtail or sump
drains63. But in 30% to 50%, it may fail or not advisable because of 
considerable necrosis, multilocularity or severely ill patient.
Acute pseudocyst is seen in 5-10% of patient with acute pancreatis
. about 40% of these, especially those without ductal communication
and those with are less than 5-6 cm in diameter resolve
spontaneous. A pseudocyst lead to pressure effect before at least 6
weeks is best treated by an initial percutaneous USG/CT guided 
therapeutic  aspiration.  The  aspiration  is  followed  by  ERCP, and if
pancreatic ductal leak is demonstrated, the duct is stented. If these
procedure fails, the cyst is drain to exterior by conventional or
laparoscopic surgery. Observation beyond 6 weeks permits maturation of
the cyst wall. At this point of time, several treatment option are
available. A cyst less than 5 cm in diameter is just observed. Cyst more
than 5 cm in diameter are drained into jejunum, stomach, or
duodenum, depending on the local anatomy: for this internal drainage,
laparoscopic surgery is slowly superceding conventional surgery (and is
practiced successfully by increasing number of Indian surgeon, notable
among these being Udwadia, Chowbey, Palanivellu and Thanakumar). A
current non-surgical option is endoscopic transgastric or transduodenal  
stenting of  the  cyst51.
Fig 23:- Intraoperative view of Cystogastrostomy
Gastrointestinal fistula is a rare complication and are due to
autodigestive necrotic process. Upper left colon is the most frequent site.
The left colonic fistula is best managed by diversion loop ileostomy(
transverse mesocolon is usually severely  edematous  and  
foreshortened)
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At times, fistula is multiple. Development of gastrointestinal
fistula adversely affects prognosis 64,65.
Pancreatic ascites is managed by repeated ascetic tap, TPN,
somatostatin or octreotide to reduced pancreatic secretion are tried as 
conservative therapy for  3  weeks.
If there is no improvement beyond 3 weeks, ERCP stenting of 
pancreatic duct is done initially. Then resection or drainage surgery
done. Pancreatic pleural effusion  disappear  once  abdominal  cause or
ascites is corrected.
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METHODS AND MATERIALS
The study group has evaluated 100 consecutive patient with clinical,
biochemical and radiological diagnosis of acute pancreatitis admitted to
hospitals attached to Madras Medical College between M a r c h  2014 to
August 2014 . It’s a prospective Hospital base study.
INCLUSION CRITERIA:
 Patients who provisionally diagnosed as acute pancreatitis
EXCLUSION CRITERIA:
 Patient who provisionally diagnosed as chronic pancreatitis
All the patients were evaluated thoroughly at the time of admission
and frequently at the in those showed deterioration their clinical status to
find out associated local/ systemic complication
Blood sample for laboratory studied on admission was drawn
in the ICU  / general ward prior to intravenous infusion.
Initial conservative management consists of nasogastric suction, 
intravenous administration of fluid, antibiotic and supportive care in all
patient.
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An indwelling urinary catheter was placed in most patient to allow
close monitoring of urine output, and a CVP catheter was frequently
introduced.ancreatitis
 Development  of  systemic  complication
1. Shock(systolic BP <90 mmHg)
2. Pulmonary insufficiency PO2< 60mmHg or less require
ventilation or O2 therapy.
3. Renal  failure(output<400ml/24 Hours), serum creatinine>2mg%
4. Severe  metabolic  disturbance(serum  calcium7.5mg/dl or less)
 Development  of  local  complication
 Pancreatic pseudocyst
 Pancreatic necrosis
 Pancreatic abscess
 Pancreatic ascites, pleural  effusion, fistula
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STATISTICS
Data was processed using excel software programme observation are 
represented as  Bar  diagram and  Pie  chart.
RESULTS
A total of 100 consecutive patient w h o  p r o v i s i o n a l l y  
d i a g n o s e d  as acute pancreatitis were entered in the study group. All
had an admission of acute pancreatitis and satisfied  the  inclusion  
criteria.
TYPE OF COMPLICATIONS
Out of 100 patients 31(31%) developed only one local complications,
7(7%) developed isolated systemic complication,10 
(10%)developed more than one local  complication and 
12(12%) developed both systemic and local  complication
SEX DISTRIBUTION
Out of 100 patients 93(93%) were male and 7 (7%) were female. Sex
ratio is 13.2: 1.
Out of 93 males 31 developed single local complications and 11 had 
both systemic and local complication and 6 developed o n l y systemic
complications.
Out of 7 female 1 developed both systemic and local complication
and 1 developed systemic complications
Table 6 : Sex Distribution
SEX LOCAL 
COMP.
SYSTEMIC 
COMP.
BOTH >1 LOCAL 
COMP.
TOTAL PERCENT
AGE
MALE 31 6 11 10 58 58%
FEMALE 0 1 1 0 2 2%
TOTAL 31 7 12 10 60 60%
Fig 24:- Sex Distribution
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No of 
male
No of 
female
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100 patient Other clinical
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sign was seen in 6 cases associated with 
       CLINICAL FEATURE
   ABDOMINAL PAIN
   VOMITING
  ABDOMINAL DISTENSION
  FEVER
  JAUNDICE
NO OF PATIENTS
was the presenting complaint in almost
feature includes vomiting in 82,
8 and.Patients Cullen’s sign and
severe necrotizing pancreatitis.
Table 8 : Clinical Features
         NO OF PATIENT            PERCENTAGE%
                    100                      100%
                     82                       82%
                     42                       42%
                     9                        9%
                     8                        8%
Fig 26:- Clinical Features
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Table 9 : ETIOLOGY
           No of patient (n=100)              Percentage %
                      72                    72%
                      16                    16%
                      3                     3%
                      9                    9%
                   100                  100%
Fig 27:- ETIOLOGY
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Table 10 : SYSTEMIC
              Systemic complications
ARF+PANCREATIC NECROSIS
ARF+PSEUDOCYST
SEPTICEMIA+PANCREATIC NECROSIS
SEPTICEMIA+PSEUDOCYST
ARDS+PANCREATIC NECROSIS
ARDS+PSEUDOCYST
HYPOCALCEMIA+PANCREATIC NECROSIS
HYPOCALCEMIA+PSEUDOCYST
HYPOCALCEMIA+ASCITIS
HYPOCALCEMIA ALONE
ARDS ALONE
Fig 28:
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DISCUSSION
The early identification of potentially severe acute pancreatitis
enables the selection of patients who may require more intensive and
invasive method of management than are appropriate in mild pancreatitis.
Most of the patients with associated with systemic complication were
managed in general ward expect few patients who are associated with 
septicemia and ARDS.
In this study laboratory test done are simple, routine and readily
available. These investigations were used to identifying systemic
complication. Local complication was diagnosed by USG/ CT scan.
In this study complication was 21.5 times more common in male
than female (M:F:21.5:1 In Ranson study male sex incidence is higher
(M:F=3.7:1) where in Imries study female sex incidence is higher
(M:F=1:1.3) the male sex incidence in study is higher because of
higher incidence of alcoholic pancreatitis. In India consumption of
alcohol in female is very low compare to western countries.
The mean age group
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common in Female in
etiological factor accounting
stone 16%. This is consistent
was found to be higher
was higher.
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basic blood investigation, chest x ray to find out associated
complication. Erect abdominal x ray was not much helpful in 
diagnosis, but it had a advantage to rule out acute abdominal
condition like perforation and intestinal obstruction.
In our study USG abdomen done in all patients but at the time of
admission inconclusive in most of patients because pancreas could not
be visualized due to full bowel loops.
USG was helpful to identify local complications such as
pseudo cyst and abscess. But it had the added advantage of being
noninvasive and could be repeated at frequent interval when require and
also as bed side procedure. It was inaccurate in detecting pancreatic
necrosis but could localized pancreatic edema, per pancreatic fluid 
collection, gall stone, biliary sludge, ascites and pseudo cyst.
CT scan in this study was a very sensitive non invasive tool in
diagnosis of pancreatitis and associated complication. Contrast
enhanced could differentiate necrosis.
Regarding management all patients, diagnosed to have acute
pancreatitis evaluated clinically, laboratory and radio logically.
According to complication and severity patient were managed in 
general ward and ICU.
81% patients with systemic complication were managed in
general ward and 19% in ICU those associated with septicemia and 
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ARDS.
Conservative management includes NPO, iv fluid, antibiotics.
Analgesic, TPN and electrolyte imbalance. The average fluid
requirement was 5L/day.regarding antibiotics 3rd generation
cephalosporins (cefotaxime) were given to all patients with systemic
complication admitted in general ward and Piperacillin + Tazobactum
those associated with septicemia and ARDS. Use of cefotaxime 
decreases the chance of infection in local complication.
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CONCLUSION
Acute pancreatitis is one of the common differential diagnoses of
acute abdomen especially in alcoholic and biliary calculi. Acute
pancreatitis patients present with acute onset of abdominal pain radiates
to back, associated with raised serum lipase.
Acute pancreatitis patients should be evaluated thoroughly
clinically, blood investigation and radiological as this condition is
associated with many complication both systemic and local. Early
diagnosis is essential to manage the complication and decrease 
mortality.
Most systemic complications are associated with hypovolemia
and systemic infection where as local complications are associated with 
pseudocyst/necrosis. Serum lipase is elevated in all patients 2-3 times and 
>5 times in pancreatic necrosis.
Investigations of complicated pancreatitis required hematological
and biochemical investigation to identify systemic complications where
USG/CT needs to identify local complications
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Management of complicated pancreatitis consists of supportive
care and conservative management for systemic complication. Local
complications are managed by conservative as well as operative
procedure. Most pseudocyst < 6 cm size is managed by USG abdomen
follow up. Pancreatic necrosis is managed by nacrosectomy+ close 
drain. Abscesses were managed by USG/CT guided aspiration.
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SUMMARY
 The study includes a total of 100 patients of complicated pancreatitis.
93 male and 7 female.
 The peak incidence in male is 5th decade in life and in female 2rd
decade in life.
 Alcohol accounts 72% total cases where as gall stone contributes
16%,idiopathic in 9% and post ERCP 3%
 Serum lipase raise in 2-3 fold in all patients expect in pancreatic
necrosis where serum lipase raise in 5 fold.
 All the patients were investigated to find out complication( systemic/
local)
 Systemic complications were diagnosed by routine blood
investigation, RFT, LFT, serum calcium and chest X ray.
 Local complications were diagnosed by USG abdomen and CT scan.
 31 patients found to have only one local complications, 10 patients had 
more than one local complications,12 patients had both local and 
systemic complications and 7 patients had only systemic complication 
out of 7 patient with systemic complications only one patient died of 
ARDS.
 Most systemic complication were managed in general wards except
few patients in ICU those were associated with septicemia and ARDS.
100
 Systemic complication were managed with supportive and conservative
 Local complications were managed with conservative and operative 
procedure.
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PROFORMA
PATIENT DETAILS:
ON ADMISSION:
Name: Age: Sex: IP No. :     Date:
HISTORY:
1. Duration of abdominal pain –
2. H/o pain radiating to back- yes/no
3. H/o vomiting- yes / no
4. H/o Anorexia- yes / no
5. H/o fever - yes / no
6. H/o pale clay color stool - yes/ no
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7. H/o abdominal distension – yes/no
8. H/o alcohol intake - yes /                                                                                                            
If yes-amount and duration
9. H/o drug intake - yes / no
10.If yes – name of drug/duration/dose
11.H/o any ERCP procedure- yes / no
12.H/o similar illness in past- yes / no
                                                                                                                                     
CLINICAL EXAMINATION:
VITAL SIGNS
Pulse:                             BP: Temp:
SYSTAMIC  EXAMINATION
CVS :
RS :
ABDOMEN ;
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       INSPECTION ;
      PALPATION ;
       AUSCULTATION ;
       PR;
INVESTIGATIONS :
Hemogram:
Renal Function Test:
Liver Function Test;
Sr.amylase & lipase:
Fasting lipid profile;
Sr.calcium;
Ultrasound:
CXR:
CECT abdomen;
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Other;
PROVISIONAL DIAGNOSIS-
MANAGEMENT 
      •   NPO
      •   IVF
      • ANALGESIC
      • Inj.Pantoprazole
     • Inj.octreotide
     • Antibiotic 
     • Vital monitoring
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CONDITION ON DISCHARGE
FOLLOW UP;
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KEY TO MASTER CHART
PE - Pancreatic Enlargement
PN   -Pan crea t ic  Necros i s
PS -Pseudocyst
FF - Pancreatic Ascites
BC - Biliary Calculi
PN - Pancreatic Necrosis
CECT - Contrast Enhancing Computed 
Tomography 
USG - Ultrasonography
N     -   NORMAL FATING LIPID PROFILE
E     -    ELEVATED FASTING LIPID PROFILE
N - No follow up
NC - No complaint
RAB - Recurrent Abdominal Pain
HC  - Hypocalcemia
NC – No complications
NFU – No follow up
ID  -  Idiopathic
BI  -  Biliary
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1 SIVAGNANAM 32 M AP+AD 2 YES NO NO NO NO NO NO 1876 2134 PE+FF E 9.5 PE+FF AL PN+FF ARDS 15 NFU
2 BABU 49 M AP+VO 3 YES NO NO NO NO NO NO 384 455 PE E 9.2 PE AL 10 NFU
3 MALAR 26 F AP+VO+AD 5 NO YES NO NO NO YES NO 689 986 BC+FF N 8 BC+FF+PE BI FF HC 7 RAB
4 RAMESH 31 M AP+VO+AD 6 YES NO NO NO NO NO NO 876 987 PE+PS N 8.7 PE+PS AL PS 14 NC
5 RAJAMANIKKAM 52 M AP+VO 3 YES NO NO NO NO NO NO 789 765 PE E 9.2 PE AL 4 NC
6 IYYANNAR 39 M AP+VO+AD 4 YES NO NO NO NO NO NO 1433 1456 PE+PS E 9.1 PE+PS AL PS 8 RAB
7 BABU 42 M AP+VO 4 NO YES NO NO NO NO NO 102 658 BC E 9.5 BC+PE BI 6 NC
8 RADHAKRISHNAN 33 M AP+VO 3 YES NO NO NO NO YES NO 988 1409 PE E 8.9 PE AL 7 NFU
9 VENKAT 30 M AP+VO+AD 5 YES NO NO NO NO NO NO 1690 2009 PE+FF E 9 PE+FF+PN AL PN+FF 13 RAB
10 MURUGAN 50 M
AP+VO
2 YES NO NO NO NO NO NO 1807 2097 PE E 9.6 PE AL 8 NC
11 SEKAR 45 M AP+VO 3 NO YES NO NO NO NO NO 679 896 BC N 9.1 BC+PE BI 7 RAB
12 ANTHONY 32 M AP 3 YES NO NO NO NO NO NO 890 1008 PE N 8.9 PE AL 5 NC
13 MUTHUSAMY 50 M AP+VO+AD 4 YES NO NO NO NO NO NO 1378 1678 PE E 7.9 PE+PS AL PS HC 10 RAB
14 MANIKANNDAN 30 M AP+VO+AD 5 YES NO NO NO NO YES NO 1876 1987 PE+PN N 8.9 PE+PN AL PN 15 RAB
15 SHANMUGAM 26 M AP 3 NO NO NO NO NO NO NO 567 879 N STUDY N 9.1 PE ID 6 NC
16 VIJAYAKUMAR 60 M AP+VO 6 YES NO NO NO NO NO NO 2098 2287 FF E 8.9 PE+FF+PN AL PN
ARDS,SEP
TICEMIA 16 NFU
17 VADIVEL 45 M AP 5 YES NO NO NO NO YES NO 76 644 PE N 7.8 PE AL HC 7 NC
18 ANANDHA 35 M AP+VO 4 NO NO NO NO NO NO NO 789 908 N STUDY N 8.7 PE ID 8 NFU
19 ELIZABETH 43 F AP+VO 5 NO YES NO NO NO NO NO 978 1009 BC N 9 BC+PE BI
ARDS,CAR
DIO RESP 
ARREST 2 NC
20 VENKATESH 38 M AP+VO 2 YES NO NO NO NO NO NO 609 876 N STUDY N 9.9 PE AL 5 NC
21 KARTHICK 29 M AP+VO+AD 5 YES NO NO NO NO YES NO 1807 2234 PE+FF N 9.6 PE+FF+PN AL PN+FF 10 RAB
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22 VEERABABU 68 M AP+V0 5 NO YES NO NO
ER
CP NO NO 103 345 N STUDY E 8.5 PE
POST 
ERCP 7 NFU
23 KANNAN 49 M AP+VO 4 YES NO NO NO NO NO NO 76 509 PE E 8.8 PE AL 6 RAB
24 KUMAR 40 M AP+VO+AD 6 YES NO NO NO NO NO NO 789 1265 PS N 9 PE+PS AL PN
SEPTICEM
IA+ARF 12 NC
25 SARAVANAN 40 M AP+VO 3 YES NO NO NO NO NO NO 897 765 PE E 9.7 PE AL 12 RAB
26 PANDHYALAKSHMI 26 F AP+VO 2 NO YES NO NO NO YES NO 765 986 BC N 9.5 BC+PE BI 7 NFU
27 JEYARAMAMN 48 M AP+VO+AD 1 YES NO NO NO NO NO NO 95 756 FF E 9.3 PE+FF AL 5 NC
28 DEVARAJ 51 M AP+VO 2 YES NO NO NO NO NO NO 98 806 N STUDY E 8.9 PE+PS AL PS 11 NC
29 MALARVANNAN 47 M AP+AD 4 YES NO NO NO NO NO NO 2105 1256 PE E 8.6 PE+PN AL PN
SEPTICEM
IA+ARF 18 NC
30 KUMAR 38 M AP+VO 2 YES NO NO NO NO NO NO 1098 1546 PE N 9 PE AL 7 NC
31 SELVAM 27 M AP+VO+AD 3 YES NO NO NO NO NO NO 657 987 FF N 9.3 PE+FF AL 6 RAB
32 SATHYADEV 51 M AP+VO+AD 2 YES NO NO NO NO NO NO 1123 1032 PE+PS E 8.9 PE+PS AL PS
SEPTICEM
IA 8 NFU
33 ELUMALI 39 M AP+VO 4 NO NO NO NO NO YES NO 75 698 BC E 8.1 PE+BC BI HC 6 RAB
34 MUNUSAMY 48 M AP+VO+AD 3 YES NO NO NO NO NO NO 108 907 FF E 9 PE+FF AL 5 NC
35 DAS 25 M AP 3 YES NO NO NO NO NO NO 97 768 N STUDY N 9.4 PE AL 6 NC
36 RANJITH 25 M AP+VO 4 NO NO NO NO NO YES NO 109 897 N STUDY N 9.3 PE ID 7 NFU
37 JAYARAMAN 45 M AP+VO 2 YES NO NO NO NO NO NO 897 1098 FF E 9.7 PE+FF AL 6 NC
38 MOORTHY 55 M AP+VO+AD 1 YES NO NO NO NO YES NO 1567 1897 PE+PN E 7.9 PE+PN AL PN HC 12 RAB
39 KUMARAS 50 M AP+VO 1 YES NO NO NO NO NO NO 1366 1678 PE+PS E 9.8 PE+PS AL PS
PSEUDOC
YST 11 RAB
40 RAJESH 26 M AP 2 NO NO NO NO NO NO NO 96 454 BC N 8.9 PE+BC BI 4 NC
41 PANNOR 45 M AP 1 YES NO NO NO NO NO NO 109 768 N STUDY N 8.8 PE AL 7 NC
42 SURESH 23 M AP+VO 2 NO NO NO NO NO NO NO 89 453 N STUDY N 8.6 PE ID 8 NC
43 RAJA 31 M AP+VO+AD 3 YES NO NO NO NO NO NO 1985 2987
PE+FF+P
N N 8.9 PE+FF+PN AL PN ARDS 15 RAB
44 KUMAR 50 M AP 1 YES NO NO NO NO NO NO 110 567 PE E 9.8 PE AL 5 NC
45 CHELLAMUTHU 45 M AP+VO+AD 4 YES NO NO NO NO NO NO 1009 1456 PS E 9.6 PE+PS AL PS 9 RAB
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46 CHEVAPATHY 46 M AP+VO+AD 2 YES NO NO NO NO YES NO 1987 2390 PE+PN N 9 PE+PN AL PN
SEPTICIMI
A+ARF 19 NC
47 GIRI 35 M AP+VO 3 NO NO NO NO NO NO NO 83 322 N STUDY N 8.8 PE ID 7 RAB
48 BHARATHI 57 M AP 5 NO NO NO NO
ER
CP NO NO 876 654 N STUDY E 8.8 PE
POST 
ERCP 8 NC
49 KUPPAN 37 M AP+VO+AD 4 YES NO NO NO NO NO NO 1876 2256 FF+PN N 7.8 PE+FF+PN AL PN+FF HC 17 RAB
50 PAROSING 54 M AP+VO 3 YES NO NO NO NO NO NO 981 1009 PE E 8.6 PE AL 7 NC
51 DHINAGARAN 35 M AP+VO+AD 5 YES NO NO NO NO NO NO 1123 1567 PE+PN N 9 PE+PN AL PN 11 RAB
52 RAJA 50 M AP+VO 4 YES NO NO NO NO NO NO 679 905 N STUDY E 9.7 PE AL 5 NC
53 ABDHUL 26 M AP 2 NO NO NO NO NO NO NO 112 541 N STUDY N 9.4 PE ID 7 NC
54 KASIF 20 F AP+VO+AD 1 NO YES NO NO NO NO NO 907 905 BC N 8.7 BC+PE BI 7 RAB
55 DEVA 43 M AP+VO+AD 1 YES NO NO NO NO NO NO 2108 2221 PS E 8.9 PE+PS AL PS 11 NC
56 SENTHIL 32 M AP 1 NO NO NO NO NO NO NO 92 457 PS N 9 PE+PS ID PS 13 RAB
57 MURUGAN 47 M AP+VO 2 YES NO NO NO NO NO NO 98 908 PE N 9.9 PE+BC BI 8 NC
58 MOORTHY 40 M AP+VO 1 NO NO NO NO NO YES NO 112 896 BC E 10 BC+PE AL 5 NFU
59 ARUL 33 M AP+VO+AD 3 YES NO NO NO NO NO NO 1908 2190 FF+PN N 10 PE+FF+PN AL PN 13 RAB
60 JEYARAMAMN 40 M AP+VO 2 NO NO NO NO NO NO NO 98 650 BC N 9.4 BC+PE BI 9 NC
61 MAHENDRAN 34 M AP 4 NO NO NO NO NO NO NO 567 1665 BC N 9.9 BC+PE BI 7 NC
62 SUDHAKAR 34 M AP+VO+AD 2 YES NO NO NO NO YES NO 1256 1009 PS N 8.9 PE+PS AL PS 9 RAB
63 BOOPATHY 39 M AP+VO+AD 3 NO NO NO NO NO NO NO 1123 1098 BC+PS E 9 PE+PS BI PS 9 RAB
64 KANNIAMMAL 36 F AP+VO+AD 2 YES NO NO NO NO NO NO 875 1006 PE E 8.9 PE AL 7 NC
65 SELVARAJ 53 M AP+VO 1 YES NO NO NO NO NO NO 458 1769 PE E 9.6 PE AL 7 RAB
66 ANBAHAGAN 51 M AP+VO 3 YES NO NO NO NO NO NO 976 1096 PE E 8.6 PE AL 6 RAB
67 MANOHARAN 42 M AP 2 YES NO NO NO NO NO NO 798 960 N STUDY E 9 PE AL 7 NC
68 MANIKANNDAN 58 M AP+VO 4 YES NO NO NO NO NO NO 678 677 PE E 9.8 PE AL 16 NC
69 LUKKA 30 M AP+VO+AD 2 NO YES NO NO
ER
CP YES NO 1123 1034 FF+PN N 10 PE+FF+PN
POST 
ERCP PN+FF 15 NFU
70 RAMESH 41 M AP+VO 1 NO NO NO NO NO NO NO 807 1098 BC E 10 PE+BC BI 7 NC
71 VELU 35 M AP+VO+AD 1 YES NO NO NO NO NO NO 1765 1658 PS N 9.8 PE+PS AL PS ARDS 18 RAB
72 VELAYDHAM 50 M AP+VO+AD 3 YES NO NO NO NO YES NO 764 1457 N STUDY E 9.9 PE AL 6 NC
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73 KANNAN 49 M AP 1 NO NO NO NO NO NO NO 98 698 N STUDY N 9.4 PE ID 7 NC
74 PRIYA 31 F AP 2 YES NO NO NO NO NO NO 897 908 PE E 9.4 PE AL 8 RAB
75 RAJA 45 M AP+VO+AD 3 YES NO NO NO NO NO NO 1087 1145 FF+PN E 9.2 PE+FF+PN AL PN+FF 14 NC
76 ANTHONY 40 M AP+VO+AD 4 YES NO NO NO NO NO NO 1894 2098 PE+PN E 9 PE+PN AL PN 14 NFU
77 KANNAN 40 M AP+VO 5 NO NO NO NO NO NO NO 58 346 BC N 8.9 BC+PE BI 9 RAB
78 FRANCIS 56 M AP+VO 3 YES NO NO NO NO NO NO 1276 1156 PE E 8.3 PE AL HC 6 NC
79 ANBANZHAGAN 51 M AP 2 YES NO NO NO NO NO NO 678 1786 PE E 10 PE AL 7 NC
80 GOVINDASAMY 48 M AP+VO 3 YES NO NO NO NO NO NO 87 675 N STUDY E 10 PE AL 8 NC
81 RAJA 42 M AP+VO+AD 1 YES NO NO NO NO YES NO 695 890 PE E 8.9 PE AL 6 RAB
82 MANI 57 M AP+VO 3 YES NO NO NO NO NO NO 543 676 PE E 8 PE AL HC 8 NC
83 MOHID 45 M AP 2 YES NO NO NO NO NO NO 54 543 PE E 11 PE AL 7 NC
84 SAMBASIVAM 32 M AP+VO+AD 4 YES NO NO NO NO NO NO 457 1678 PS N 11 PE+PS AL PS ARDS 18 RAB
85 ABDUL 30 M AP+VO 1 YES NO NO NO NO NO NO 564 698 N STUDY N 9.5 PE AL 7 NC
86 RAJAN 25 M AP+VO+AD 3 YES NO NO NO NO NO NO 2654 2679 PS N 9.3 PE+PS AL PS 8 RAB
87 MANOHARAN 50 M AP 2 YES NO NO NO NO NO NO 578 904 PE E 9.1 PE AL 9 NC
88 UMA 40 F AP+VO 4 NO NO NO NO NO YES NO 456 1896 BC E 9.7 BC+PE BI 6 NC
89 SUBRAMANI 28 M AP+VO+AD 2 YES NO NO NO NO YES NO 1789 1896 PE+PN N 8.9 PE+PN AL PN 11 NFU
90 RAJAN 25 M AP+VO+AD 2 YES NO NO NO NO NO NO 64 890 N STUDY N 8.4 PE AL HC 9 NC
91 KODHANDAN 35 M AP+VO 2 NO NO NO NO NO NO NO 110 586 N STUDY N 8.6 PE ID 7 RAB
92 GUNASEKARAN 53 M AP+VO 1 YES NO NO NO NO NO NO 455 1765 PE E 9.4 PE AL 7 NC
93 SURESH 45 M AP 4 YES NO NO NO NO NO NO 897 902 PE E 9.4 PE AL 8 NC
94 RAMESH 32 M AP+VO+AD 3 YES NO NO NO NO NO NO 1765 1795
FF+PN+P
E N 9.3 PE+PN+FF AL PN 13 RAB
95 RAMAMMORTHY 45 M AP+VO 2 YES NO NO NO NO NO NO 890 674 PE E 9.7 PE AL 8 NC
96 JEYARAMAN 51 M AP+VO 1 YES NO NO NO NO NO NO 48 765 PE E 9.5 PE AL 6 NFU
97 ANTHONY 40 M AP+VO+AD 4 YES NO NO NO NO NO NO 46 896 BC E 9.1 BC+PE BI 5 RAB
98 CHANDRAN 20 M AP+VO 1 YES NO NO NO NO NO NO 1960 2083 N STUDY N 9.3 PE AL 7 NC
99 SILAMBARASAN 27 M AP+VO 2 YES NO NO NO NO NO NO 108 787 PE N 8.4 PE AL HC 8 NFU
100 KRISHNAN 46 M AP+VO+AD 3 YES NO NO NO NO NO NO 1045 1437 PS E 10 PE+PS AL PS 7 NC


